Amino Collective

Amino Collective is a Berlin-based venture capital firm with a primary focus on health and biotechnology. They specialize in backing early-stage ventures, especially those in the pre-seed to Series A stages, with investments ranging from $250,000 to $5 million. The firm is deeply committed to transforming healthcare through strategic partnerships with entrepreneurs and scientists who are pushing the boundaries of bio and health tech. Amino Collective's mission is to bring life-changing ideas to fruition, supporting founders who are "free and radical," unafraid to challenge established norms. The fund primarily targets European-based startups with the ambition to scale globally. Notable investments include Lindus Health, Molecule, and Nostos Genomics. Led by co-founders like Manuel Grossmann, Amino Collective is not just about providing capital but also about offering mentorship and fostering innovation in sectors like digital health, medical devices, and biotech. Their approach is focused on long-term impact, aiming to shape a better future by leveraging the latest advancements in science and technology.